Detalles de la búsqueda
1.
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.
Br J Haematol
; 190(5): 736-740, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236950
2.
Five-year survival follow-up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic leukaemia: a short report.
Br J Haematol
; 189(4): 689-693, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31994178
3.
A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial.
Leuk Lymphoma
; 61(7): 1748-1751, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107948
Resultados
1 -
3
de 3
1
Próxima >
>>